Short-term effects of intravitreal bevacizumab in type ii idiopathic macular telangiectasia.


PURPOSE To report the effect of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia (type 2 IMT). DESIGN Interventional case report. METHODS A 51 year-old female patient with type 2 IMT presented with gradual visual deterioration and reading difficulties. In one affected eye, two intravitreal bevacizumab injections were performed with a… (More)
DOI: 10.1097/ICB.0b013e31809ed9b6


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics